Morgan Hakki

2.5k total citations
41 papers, 1.8k citations indexed

About

Morgan Hakki is a scholar working on Epidemiology, Infectious Diseases and Oncology. According to data from OpenAlex, Morgan Hakki has authored 41 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Epidemiology, 12 papers in Infectious Diseases and 10 papers in Oncology. Recurrent topics in Morgan Hakki's work include Cytomegalovirus and herpesvirus research (22 papers), Herpesvirus Infections and Treatments (16 papers) and Antibiotic Resistance in Bacteria (8 papers). Morgan Hakki is often cited by papers focused on Cytomegalovirus and herpesvirus research (22 papers), Herpesvirus Infections and Treatments (16 papers) and Antibiotic Resistance in Bacteria (8 papers). Morgan Hakki collaborates with scholars based in United States, Australia and Sweden. Morgan Hakki's co-authors include Michael Boeckh, Per Ljungman, Adam P. Geballe, Sunwen Chou, James S. Lewis, Janet F. Staab, Kieren A. Marr, Lawrence Corey, Stephanie J. Child and Emily E. Marshall and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Morgan Hakki

38 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Morgan Hakki United States 23 1.5k 531 383 295 227 41 1.8k
Nikolaos G. Almyroudis United States 21 1.0k 0.7× 1.1k 2.0× 310 0.8× 353 1.2× 40 0.2× 35 1.7k
M C Jordan United States 23 1.3k 0.9× 177 0.3× 202 0.5× 390 1.3× 221 1.0× 30 1.4k
Jo‐Anne H. van Burik United States 19 1.1k 0.7× 930 1.8× 473 1.2× 201 0.7× 34 0.1× 24 1.9k
Angela Bacci Italy 23 1.3k 0.9× 1.6k 3.0× 160 0.4× 1.1k 3.7× 59 0.3× 26 2.5k
John E. Pearl United States 19 1.3k 0.9× 1.7k 3.2× 351 0.9× 2.2k 7.3× 68 0.3× 25 3.2k
Buka Samten United States 30 1.1k 0.8× 1.3k 2.4× 146 0.4× 904 3.1× 23 0.1× 64 2.3k
Giuseppe Del Sero Italy 17 894 0.6× 1.1k 2.0× 122 0.3× 740 2.5× 105 0.5× 20 1.8k
Luis F. Barrera Colombia 19 628 0.4× 861 1.6× 100 0.3× 620 2.1× 37 0.2× 40 1.4k
Malcolm P. France Australia 9 679 0.5× 829 1.6× 163 0.4× 621 2.1× 37 0.2× 11 1.6k
Radha Gopal United States 20 663 0.5× 865 1.6× 156 0.4× 938 3.2× 87 0.4× 34 1.6k

Countries citing papers authored by Morgan Hakki

Since Specialization
Citations

This map shows the geographic impact of Morgan Hakki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morgan Hakki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morgan Hakki more than expected).

Fields of papers citing papers by Morgan Hakki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Morgan Hakki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morgan Hakki. The network helps show where Morgan Hakki may publish in the future.

Co-authorship network of co-authors of Morgan Hakki

This figure shows the co-authorship network connecting the top 25 collaborators of Morgan Hakki. A scholar is included among the top collaborators of Morgan Hakki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Morgan Hakki. Morgan Hakki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khawaja, Fareed, Danniel Zamora, Michelle K. Yong, et al.. (2025). American Society for Transplantation and Cellular Therapy Series #11: Updated Cytomegalovirus Guidelines in Hematopoietic Cell Transplant and Cellular Therapy Recipients. Transplantation and Cellular Therapy. 31(10). 727–741.
2.
Zhang, Liyang, et al.. (2025). Role of R5 pyocin in the predominance of high-risk Pseudomonas aeruginosa isolates. Microbiological Research. 299. 128244–128244.
3.
Hanson, Blake, An Q Dinh, Rodrigo P. Baptista, et al.. (2024). Cefiderocol heteroresistance associated with mutations in TonB-dependent receptor genes in Pseudomonas aeruginosa of clinical origin. Antimicrobial Agents and Chemotherapy. 68(8). e0012724–e0012724. 10 indexed citations
4.
5.
Zhang, Liyang, et al.. (2022). Long-Term Dominance of Carbapenem-Non-Susceptible Pseudomonas aeruginosa ST111 in Hematologic Malignancy Patients and Hematopoietic Cell Transplant Recipients. Frontiers in Cellular and Infection Microbiology. 12. 904602–904602. 4 indexed citations
6.
Hakki, Morgan, Samuel L Aitken, Lara Danziger‐Isakov, et al.. (2021). American Society for Transplantation and Cellular Therapy Series: #3—Prevention of Cytomegalovirus Infection and Disease After Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy. 27(9). 707–719. 67 indexed citations
7.
Hakki, Morgan. (2020). Moving Past Ganciclovir and Foscarnet: Advances in CMV Therapy. Current Hematologic Malignancy Reports. 15(2). 90–102. 32 indexed citations
8.
Ramanan, Poornima, Sias Scherger, Esther Benamu, et al.. (2019). Toxoplasmosis in non‐cardiac solid organ transplant recipients: A case series and review of literature. Transplant Infectious Disease. 22(1). e13218–e13218. 12 indexed citations
9.
10.
Crawford, Lindsey B., Daniel N. Streblow, Morgan Hakki, Jay A. Nelson, & Patrizia Caposio. (2015). Humanized mouse models of human cytomegalovirus infection. Current Opinion in Virology. 13. 86–92. 46 indexed citations
11.
Iwahori, Satoko, Morgan Hakki, Sunwen Chou, & Robert F. Kalejta. (2015). Molecular Determinants for the Inactivation of the Retinoblastoma Tumor Suppressor by the Viral Cyclin-dependent Kinase UL97. Journal of Biological Chemistry. 290(32). 19666–19680. 27 indexed citations
12.
Hakki, Morgan, et al.. (2013). HCMV Infection of Humanized Mice after Transplantation of G-CSF–Mobilized Peripheral Blood Stem Cells from HCMV-Seropositive Donors. Biology of Blood and Marrow Transplantation. 20(1). 132–135. 32 indexed citations
13.
Chou, Sunwen, Morgan Hakki, & Stephen Villano. (2012). Effects on maribavir susceptibility of cytomegalovirus UL97 kinase ATP binding region mutations detected after drug exposure in vitro and in vivo. Antiviral Research. 95(2). 88–92. 22 indexed citations
14.
Ljungman, Per, Morgan Hakki, & Michael Boeckh. (2011). Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients. Hematology/Oncology Clinics of North America. 25(1). 151–169. 312 indexed citations
15.
Hakki, Morgan & Sunwen Chou. (2011). The biology of cytomegalovirus drug resistance. Current Opinion in Infectious Diseases. 24(6). 605–611. 71 indexed citations
16.
Hakki, Morgan & Adam P. Geballe. (2011). Double-Stranded RNA Binding by Human Cytomegalovirus pTRS1. Journal of Virology. 85(23). 12836–12836.
17.
Ljungman, Per, Morgan Hakki, & Michael Boeckh. (2010). Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients. Infectious Disease Clinics of North America. 24(2). 319–337. 118 indexed citations
18.
Hakki, Morgan & Adam P. Geballe. (2008). Cellular serine/threonine phosphatase activity during human cytomegalovirus infection. Virology. 380(2). 255–263. 17 indexed citations
19.
Hakki, Morgan, et al.. (2007). Invasive Pseudomonas aeruginosa infections: high rate of recurrence and mortality after hematopoietic cell transplantation. Bone Marrow Transplantation. 39(11). 687–693. 57 indexed citations
20.
Hakki, Morgan, et al.. (2006). Binding and Nuclear Relocalization of Protein Kinase R by Human Cytomegalovirus TRS1. Journal of Virology. 80(23). 11817–11826. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nikolaos G. Almyroudis Breakdown of academic impact, for papers by M C Jordan Breakdown of academic impact, for papers by Jo‐Anne H. van Burik Breakdown of academic impact, for papers by Angela Bacci Breakdown of academic impact, for papers by John E. Pearl Breakdown of academic impact, for papers by Buka Samten Breakdown of academic impact, for papers by Giuseppe Del Sero Breakdown of academic impact, for papers by Luis F. Barrera Breakdown of academic impact, for papers by Malcolm P. France Breakdown of academic impact, for papers by Radha Gopal
Rankless by CCL
2026